Key statistics · As on 14 Oct 2026
Market cap
BDT 1,453.298 mn
Free float market cap
BDT 940.683 mn
NAV per share
BDT 23.02
P/E (audited)
34.63x
Day's value
BDT 2.45 mn
Day's volume
172,746
Day's trades
160
Opening price
BDT 14.30
Adjusted Opening Price
BDT 14.00
Yesterday's closing price
BDT 14.00
Closing price
BDT 14.20
Last Update
2:09 PM
Day's range
Current BDT 14.20
BDT 14.00BDT 14.40
52-week range
Current BDT 14.20
BDT 11.10BDT 23.30
Basics
- Listing year
- 2019
- Authorized Capital (mn)
- BDT 1,050
- Paid-up capital
- BDT 1,038.07 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 103,807,000
- Market Lot
- 1
Shareholding pattern
as on Jun 30, 2025 (year ended)
as on Aug 31, 2026
as on Sep 30, 2026
Sponsor / Director
35.46%
35.27%
35.27%
Government
0.00%
0.00%
0.00%
Institution
16.97%
16.34%
16.77%
Foreign
0.00%
0.00%
0.00%
Public
47.57%
48.39%
47.96%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 41 Nurani, Bankalapara, Subid Bazar, Sylhet
- Factory Address
- BSCIC, Industrial Estate, Khadim Nagar, Sylhet-3103.
- Contact Phone
- +880-02996638241
- Fax
- —
- info@silcopharma.com
- Company Secretary Name
- Mr. Tingku Ranjan Sarker
- Company Secretary Cell No.
- 8801716394060
- Company Secretary Telephone No.
- +880-02 996638241
- Company Secretary E-mail
- trt.tinku@gmail.com
- Website
- http://www.silcopharma.com/
- Loan status
- Short-term: — · Long-term: —
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 19-01-2026
- Year-end
- June
Details of Financial Statementsilcopharma.com/wp-content/uploads/2025/01/Annual-Audited-Financial-Statements-23-24.pdf
Price Sensitive Informationhttp://Price Sensitive Information (PSI) - Silco Pharmaceuticals Limited